Dr. Reddy's Laboratories Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	346,325	325,535	279,164	245,879	214,391	189,722
Revenue Growth (YoY)	11.06%	16.61%	13.54%	14.69%	13.00%	8.66%
Cost of Revenue	136,943	135,107	115,557	106,536	100,551	86,645
Gross Profit	209,382	190,428	163,607	139,343	113,840	103,077
Selling, General & Admin	29,043	93,870	77,201	68,026	62,081	54,650
Depreciation & Amortization Expenses	8,908	-	-	-	-	-
Research & Development	12,350	27,380	22,873	19,381	17,482	16,541
Other Operating Expenses	34,940	1,693	3	699	7,562	8,588
Total Operating Expenses	85,241	122,943	100,077	88,106	87,125	79,779
Operating Income	124,141	67,485	63,530	51,237	26,715	23,298
Interest Income	-	12,277	9,699	7,134	5,196	4,276
Interest Expense	-1,486	-2,829	-1,711	-1,428	-958	-970
Other Non-Operating Income (Expense)	3,417	14,575	4,346	6,277	3,464	1,462
Total Non-Operating Income (Expense)	1,931	24,023	12,334	11,983	7,702	4,768
Pretax Income	124,132	76,784	71,870	60,367	32,298	26,413
Provision for Income Taxes	7,610	19,539	16,186	15,300	8,730	9,175
Net Income	56,584	56,544	55,684	45,067	22,865	16,758
Minority Interest in Earnings	125	-484	147	370	703	480
Net Income to Common	56,584	56,544	55,684	45,067	22,865	16,758
Net Income Growth	5.36%	1.54%	23.56%	97.10%	36.44%	-11.51%
Shares Outstanding (Basic)	833	833	832	830	829	829
Shares Outstanding (Diluted)	833	834	834	832	832	832
Shares Change (YoY)	24.69%	0.07%	0.19%	0.03%	0.01%	0.14%
EPS (Basic)	67.96	67.89	66.93	54.28	28.42	20.79
EPS (Diluted)	67.96	67.79	66.80	54.17	28.34	20.73
EPS Growth	-45.49%	1.48%	23.32%	91.16%	36.70%	-11.71%
Free Cash Flow	36,656	18,924	29,030	47,552	13,448	25,962
Free Cash Flow Growth	93.70%	-34.81%	-38.95%	253.60%	-48.20%	3.86%
Free Cash Flow Per Share	-	-	34.83	57.16	16.17	31.22
Dividends Per Share	8.000	8.000	8.000	8.000	6.000	5.000
Dividend Growth	-	-	-	33.33%	20.00%	-
Gross Margin	27.42%	58.50%	58.61%	56.67%	53.10%	54.33%
Operating Margin	2.80%	20.73%	22.76%	20.84%	12.46%	12.28%
Profit Margin	16.21%	17.58%	19.95%	18.33%	10.99%	9.09%
FCF Margin	10.58%	5.81%	10.40%	19.34%	6.27%	13.68%
EBITDA	29,244	84,495	78,371	63,872	38,539	36,094
EBITDA Margin	8.44%	25.96%	28.07%	25.98%	17.98%	19.02%
EBIT	124,141	67,485	63,530	51,237	26,715	23,298
EBIT Margin	2.80%	20.73%	22.76%	20.84%	12.46%	12.28%
Effective Tax Rate	19.46%	25.45%	22.52%	25.34%	27.03%	34.74%

Updated Jan 21, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q